Antimicrobial peptide precursor structures suggest effective production strategies

Recent Patents on Inflammation and Allergy Drug Discovery

Volumn 2, Issue 1, 2008, Pages 58-63

  Vassilevski, Alexander A ^a   Kozlov, Sergey A ^a   Grishin, Eugene V ^a  

^a SHEMYAKIN OVCHINNIKOV INSTITUTE OF BIOORGANIC CHEMISTRY   (Russian Federation)

Author keywords

Antimicrobial peptides; Expression systems; Fusion proteins; Protein precursor structure; Recombinant polypeptide production

Indexed keywords

AMIDOPHOSPHORIBOSYLTRANSFERASE; BETA GALACTOSIDASE; BETA LACTAMASE; BINDING PROTEIN; CARRIER PROTEIN; CATHELICIDIN; CECROPIN; DEFENSIN; DERMASEPTIN; DROSOCIN; GLUCAN SYNTHASE; GLUTATHIONE TRANSFERASE; GREEN FLUORESCENT PROTEIN; HEVEIN; HYBRID PROTEIN; IMMUNOGLOBULIN G BINDING PROTEIN A; INDOLICIDIN; LACTOFERRICIN; MALTOSE BINDING PROTEIN; MELITTIN; OUTER MEMBRANE PROTEIN; OUTER MEMBRANE PROTEIN OPRF; POLYPEPTIDE ANTIBIOTIC AGENT; PROTEIN PRECURSOR; RECOMBINANT PROTEIN; THIONINE; THIOREDOXIN; UBIQUITIN; UNCLASSIFIED DRUG; XYLAN ENDO 1,3 BETA XYLOSIDASE;

AMINO ACID SEQUENCE; ANTIBIOTIC THERAPY; ANTIMICROBIAL ACTIVITY; CHIMERA; DRUG CYTOTOXICITY; DRUG DESIGN; DRUG STABILITY; DRUG SYNTHESIS; FERMENTATION; NONHUMAN; PATENT; PLANT PATHOGEN INTERACTION; PRIORITY JOURNAL; PROKARYOTE; PROTEIN EXPRESSION; PROTEIN STRUCTURE; PROTEIN SYNTHESIS; REVIEW; TRANSGENIC PLANT;

ANIMALS; ANTI-INFECTIVE AGENTS; ANTIMICROBIAL CATIONIC PEPTIDES; GENE EXPRESSION; HUMANS; PATENTS AS TOPIC; PLANT DISEASES; PROKARYOTIC CELLS; RECOMBINANT FUSION PROTEINS;

EID: 42149175957     PISSN: 1872213X     EISSN: None     Source Type: Journal    
DOI: 10.2174/187221308783399261     Document Type: Review

References (74)

1. Walsh C. Where will new antibiotics come from? Nat Rev Microbiol 2003; 1: 65-70.
2. Walsh C. Molecular mechanisms that confer antibacterial drug resistance. Nature 2000; 406: 775-781.
3. Zasloff M. Antimicrobial peptides of multicellular organisms. Nature 2002; 415: 389-395.
4. Brogden KA. Antimicrobial peptides: pore formers or metabolic inhibitors in bacteria? Nat Rev Microbiol 2005; 3: 238-250.
5. Finlay BB, Hancock RE. Can innate immunity be enhanced to treat microbial infections? Nat Rev Microbiol 2004; 2: 497-504.
6. Hancock RE, Lehrer R. Cationic peptides: a new source of antibiotics. Trends Biotechnol 1998; 16: 82-88.
7. Forstner M, Leder L, Mayr LM. Optimization of protein expression systems for modern drug discovery. Expert Rev Proteomics 2007; 4: 67-78.
8. Schmidt FR. Recombinant expression systems in the pharmaceutical industry. Appl Microbiol Biotechnol 2004; 65: 363-372.
9. Piers KL, Brown MH, Hancock REW. Recombinant DNA procedures for producing small antimicrobial cationic peptides in bacteria. Gene 1993; 134: 7-13.
10. Thomma BP, Cammue BP, Thevissen K. Plant defensins. Planta 2002; 216: 193-202.
11. Casteels-Josson K, Zhang W, Capaci T, Casteels P, Tempst P. Acute transcriptional response of the honeybee peptide-antibiotics gene repertoire and required post-translational conversion of the precursor structures. J Biol Chem 1994; 269: 28569-28575.
12. Vanhoye D, Bruston F, Nicolas P, Amiche M. Antimicrobial peptides from hylid and ranin frogs originated from a 150-million-year-old ancestral precursor with a conserved signal peptide but a hypermutable antimicrobial domain. Eur J Biochem 2003; 270: 2068-2081.
13. Ganz T. Defensins: antimicrobial peptides of innate immunity. Nat Rev Immunol 2003; 3: 710-720.
14. Dimarcq JL, Bulet P, Hetru C, Hoffmann J. Cysteine-rich antimicrobial peptides in invertebrates. Biopolymers 1998; 47: 465-477.
15. Vlasak R, Unger-Ullmann C, Kreil G, Frischauf AM. Nucleotide sequence of cloned cDNA coding for honeybee prepromelittin. Eur J Biochem 1983; 135: 123-126.
16. Florack DE, Stiekema WJ. Thionins: properties, possible biological roles and mechanisms of action. Plant Mol Biol 1994; 26: 25-37.
17. Kozlov SA, Grishin EV. The universal algorithm of maturation for secretory and excretory protein precursors. Toxicon 2007; 49: 721-726.
18. Zanetti M. The role of cathelicidins in the innate host defenses of mammals. Curr Issues Mol Biol 2005; 7: 179-196.
19. Lee HI, Broekaert WF, Raikhel NV. Co- and post-translational processing of the hevein preproprotein of latex of the rubber tree (Hevea brasiliensis). J Biol Chem 1991; 266: 15944-15948.
20. Kim HS, Park CB, Kim MS, Kim SC. cDNA cloning and characterization of buforin I, an antimicrobial peptide: a cleavage product of histone H2A. Biochem Biophys Res Commun 1996; 229: 381-387.
21. Yamauchi K, Tomita M, Giehl TJ, Ellison RT. 3rd. Antibacterial activity of lactoferrin and a pepsin-derived lactoferrin peptide fragment. Infect Immun 1993; 61: 719-728.
22. Terry AS, Poulter L, Williams DH, et al. The cDNA sequence coding for prepro-PGS (prepro-magainins) and aspects of the processing of this prepro-polypeptide. J Biol Chem 1988, 263: 5745-5751.
23. Casteels-Josson K, Capaci T, Casteels P, Tempst P. Apidaecin multipeptide precursor structure: a putative mechanism for amplification of the insect antibacterial response. EMBO J 1993; 12: 1569-1578.
24. Tailor RH, Acland DP, Attenborough S, et al. A novel family of small cysteine-rich antimicrobial-peptides from seed of Impatiens balsamina is derived from a single precursor protein. J Biol Chem 1997; 272: 24480-24487.
25. Marcus JP, Green JL, Goulter KC, Manners JM. A family of antimicrobial peptides is produced by processing of a 7S globulin protein in Macadamia integrifolia kernels. Plant J 1999; 19: 699-710.
26. Hancock, R.E.W., Piers, K.L., Brown, M.H., Kelly, N.: WO9628559 (1996).
27. Hancock, R.E.W., Piers, K.L., Brown, M.H.: US5593866 (1997).
28. Hancock, R.E., Piers, K.L., Brown, M.H.: WO9404688 (1994).
29. Lai, J., Lee, J.H., Lin, Y.L., Ray, D., Wilcox, G,: US5206154 (1993).
30. Kim, S.C., Lee, J.H., Kang, M.H., Kim, J.H., Hong, S.S., Lee, H.S.: US20016183992 (2001).
31. Kim, J.H., Kang, M.H., Lee, J.H., Park, S.H., Lee, J.W., Hong, S.S., Lee, H.S.: WO9964611 (1999).
32. Zhang L, Falls T, Wu M, et al. Determinants of recombinant production of antimicrobial cationic peptides and creation of peptide variants in bacteria. Biochem Biophys Res Commun 1998; 247: 674-680.
33. Capparelli R, Ventimiglia I, Palumbo D, et al. Expression of recombinant puroindolines for the treatment of staphylococcal skin infections (Acne vulgaris). J Biotechnol 2007; 128: 606-614.
34. Li Y, Li X, Wang G. Cloning, expression, isotope labeling, and purification of human antimicrobial peptide LL-37 in Escherichia coli for NMR studies. Protein Expr Purif 2000; 47: 498-505.
35. Xu X, Jin F, Yu X, et al. Expression and purification of a recombinant antibacterial peptide, cecropin, from Escherichia coli. Protein Expr Purif 2007; 53: 293-301.
36. Moon JY, Henzler-Wildman KA, Ramamoorthy A. Expression and purification of a recombinant LL-37 from Escherichia coli. Biochim Biophys Acta 2006; 1758: 1351-1358.
37. Xu Z, Peng L, Zhong Z, Fang X, Cen P. High-leve expression of a soluble functional antimicrobial peptide, human beta-defensin 2, in Escherichia coli. Biotechnol Prog 2006; 22: 382-386.
38. Zhou QF, Luo XG, Ye L, Xi T. High-level production of a novel antimicrobial peptide perinerin in Escherichia coli by fusion expression. Curr Microbiol 2007; 54: 366-370.
39. Huang L, Wang J, Zhong Z, et al. Production of bioactive human beta-defensin-3 in Escherichia coli by soluble fusion expression. Biotechnol Lett 2006; 28: 627-632.
40. Shi WJ, Xu HJ, Cheng JA, Zhang CX. Expression of the melittin gene of Apis cerana cerana in Escherichia coli. Protein Expr Purif 2004; 37: 213-219.
41. Hara, S.: US5646014 (1997).
42. Skosyrev VS, Rudenko NV, Vakhnin AV, et al. EGFP as a fusion partner for the expression and organic extraction of small polypeptides. Protein Expr Purif 2003; 27: 55-62.
43. Xu X, Jin F, Yu X, Ren S, Hu J, Zhang W. High-level expression of the recombinant hybrid peptide cecropinA(1-8)-magainin2(1-12) with an ubiquitin fusion partner in Escherichia coli. Protein Expr Purif 2007; 55: 175-182.
44. Kim, J.H., Kang, M.H., Lee, J.H., Park, S.H., Lee, J.W., Hong, S.S, Lee, H.S.: US20046699689 (2004)
45. Hwang SW, Lee JH, Park HB, et al. A simple method for the purification of an antimicrobial peptide in recombinant Escherichia coli. Mol Biotechnol 2001; 18: 193-198.
46. Jensen, E.B., Hoegenhaug, H.H.K., Hansen, P.K., Pedersen, P.E., Mygind, P.H.: WO05024002 (2005).
47. Jensen, E.B., Hogenhaug, H.H.K., Hansen, P.K., Pedersen, P.E., Mygind, P.H.: US20070104764 (2007).
48. Keeler, S.J., Hnatow, L.L.: WO05019242 (2005).
49. Cipakova I, Gasperik J, Hostinova E. Expression and purification of human antimicrobial peptide, dermcidin, in Escherichia coli. Protein Expr Purif 2006; 45: 269-274.
50. Pazgier M, Lubkowski J. Expression and purification of recombinant human alpha-defensins in Escherichia coli. Protein Expr Purif 2006; 49: 1-8.
51. Lee JH, Kim JH, Hwang SW, et al. High-level expression of antimicrobial peptide mediated by a fusion partner reinforcing formation of inclusion bodies. Biochem Biophys Res Commun 2000; 277: 575-580.
52. Wei Q, Kim YS, Seo JH, Jang WS, Lee, IH, Cha HJ. Facilitation of expression and purification of an antimicrobial peptide by fusion with baculoviral polyhedrin in Escherichia coli. Appl Environ Microbiol 2005; 71: 5038-5043.
53. Rao XC, Li S, Hu JC, et al. A novel carrier molecule for high-level expression of peptide antibiotics in Escherichia coli. Protein Expr Purif 2004; 36: 11-18.
54. Keeler, S.J., Wolstenholme, S.M., Duke, J.L., Hnatow, L.L.: US20070122425 (2007).
55. Yang YH, Zheng GG, Li G, et al. Expression of bioactive recombinant GSLL-39, a variant of human antimicrobial peptide LL-37, in Escherichia coli. Protein Expr Purif 2004; 37: 229-235.
56. He M, Liu H, Austen B. Expression and export in Escherichia coli of fusion proteins containing carboxy-terminally located honeybee prepromelittin. DNA Cell Biol 1994; 13: 875-882.
57. Kim, S.C., Lee, J.H., Kang, M.H., Kim, J.H., Hong, S.S., Lee, H.S.: WO9854336 (1998).
58. Morin KM, Arcidiacono S, Beckwitt R, Mello CM. Recombinant expression of indolicidin concatamers in Escherichia coli. Appl. Microbiol Biotechnol 2006; 70: 698-704.
59. Tian ZG, Teng D, Yang YL, et al. Multimerization and fusion expression of bovine lactoferricin derivative LfcinB15-W4,10 in Escherichia coli. Appl Microbiol Biotechnol 2007; 75: 117-124.
60. Lee JH, Minn I, Park CB, Kim SC. Acidic peptide-mediated expression of the antimicrobial peptide buforin II as tandem repeats in Escherichia coli. Protein Expr Purif 1998; 12: 53-60.
61. Kim HK, Chun DS, Kim JS, et al. Expression of the cationic antimicrobial peptide lactoferricin fused with the anionic peptide in Escherichia coli. Appl Microbiol Biotechnol 2006; 72: 330-338.
62. Burian, J., Bartfeld, D.: WO0031279 (2000).
63. Burian, J., Bartfeld D.: US20056946261 (2005).
64. Krebs, J.F., Zorner, P.S., Tomlinson, I.A.: WO03089455 (2003).
65. Krebs, J.F., Zorner, P.S., Tomlinson, I.A.: US20050227321 (2005).
66. Hall, R.H.: US3093551 (1963).
67. Mygind PH, Fischer RL, Schnorr KM, et al. Plectasin is a peptide antibiotic with therapeutic potential from a saprophytic fungus. Nature 2005; 437: 975-80.
68. Schnorr, K.M., Hansen, M.T., Mygind, P.H., Segura, D.R., Kristensen, H.H.H.: WO03044049 (2003).
69. Mygind, P.H., Hansen, M.T., Soerensen, M.V., Sandvang, D.: US2006223751 (2006).
70. Spodsberg, N.: WO07068735 (2007).
71. Hoegenhaug, H.H.K., Schnorr, K.M., Hansen, M.T.: WO06097464 (2006).
72. Daniell, H.: US2004093636 (2004).
73. Diehn, S., LU, A.L., Sims, L.E., Ward, K.R.: US2006156439 (2006).
74. Putman, R.J., Rao, A.G.: WO9516776 (1995).